Zhengye Biotechnology’s (NASDAQ:ZYBT – Get Free Report) quiet period will expire on Monday, February 17th. Zhengye Biotechnology had issued 1,500,000 shares in its initial public offering on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. During Zhengye Biotechnology’s quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
Zhengye Biotechnology Price Performance
Shares of Zhengye Biotechnology stock opened at $4.99 on Friday. Zhengye Biotechnology has a 12-month low of $3.70 and a 12-month high of $6.10.
Zhengye Biotechnology Company Profile
Featured Stories
- Five stocks we like better than Zhengye Biotechnology
- 3 Warren Buffett Stocks to Buy Now
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Using the MarketBeat Dividend Tax Calculator
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Zhengye Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhengye Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.